Johnson & Johnson: tightens up 2019 target EPS range
(CercleFinance.com) - In 2019 Johnson & Johnson now expects adjusted EPS of between 8.
84 dollars and 8.89 dollars, against 8.73 dollars to 8.83 dollars previously, with adjusted operating sales growth of 4.5% to 5%, vs. a previous forecast range of between 3.2% and 3.7%.
The health care group posted Q3 adjusted net income that is up 1.5% at 5.67 billion dollars, or 2.12 dollars per share, above the consensus of exactly two dollars.
Its revenues increased by 1.9% to 20.7 billion dollars, which were up 3.2% in operational terms (i.e. excluding currency effects). When adjusted for scope effects as well, revenues rose by 5.2%.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
84 dollars and 8.89 dollars, against 8.73 dollars to 8.83 dollars previously, with adjusted operating sales growth of 4.5% to 5%, vs. a previous forecast range of between 3.2% and 3.7%.
The health care group posted Q3 adjusted net income that is up 1.5% at 5.67 billion dollars, or 2.12 dollars per share, above the consensus of exactly two dollars.
Its revenues increased by 1.9% to 20.7 billion dollars, which were up 3.2% in operational terms (i.e. excluding currency effects). When adjusted for scope effects as well, revenues rose by 5.2%.
Copyright (c) 2019 CercleFinance.com. All rights reserved.